Technology Transfer Assistance. CytomX shall provide reasonable assistance, at no additional cost to Pfizer beyond reimbursement of FTE costs for CytomX personnel providing such assistance as provided in Section 5.3.1, to effect the timely and orderly transfer to Pfizer of the Know-How included in the Licensed Intellectual Property necessary for Pfizer’s use in performing its responsibilities under the Research Plans, and, if Pfizer exercises an Option granted to it under Section 4.1.1, for the Development, Manufacturing and Commercialization of Licensed Products pursuant to the Commercial License.
Appears in 5 contracts
Samples: Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.), Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.), Research Collaboration, Option and License Agreement (CytomX Therapeutics, Inc.)
